HELVACI, Ö. Et Al. 2024. Evaluation of the effect of IV iron therapy on eGFR and Pro-BNP in patients with chronic kidney disease and heart failure with preserved EF. 61st Congress of European-Renal-Association (ERA) , (Stockholm, Sweden).

HELVACI, Ö., SEZENÖZ, B., AY, E. I., YILDIRIM, S., YAŞAR, E., SEÇKİN GÖBÜT, Ö., ... DEMİREZEN, A.(2024). Evaluation of the effect of IV iron therapy on eGFR and Pro-BNP in patients with chronic kidney disease and heart failure with preserved EF . 61st Congress of European-Renal-Association (ERA), Stockholm, Sweden

HELVACI, ÖZANT Et Al. "Evaluation of the effect of IV iron therapy on eGFR and Pro-BNP in patients with chronic kidney disease and heart failure with preserved EF," 61st Congress of European-Renal-Association (ERA), Stockholm, Sweden, 2024

HELVACI, ÖZANT Et Al. "Evaluation of the effect of IV iron therapy on eGFR and Pro-BNP in patients with chronic kidney disease and heart failure with preserved EF." 61st Congress of European-Renal-Association (ERA) , Stockholm, Sweden, 2024

HELVACI, Ö. Et Al. (2024) . "Evaluation of the effect of IV iron therapy on eGFR and Pro-BNP in patients with chronic kidney disease and heart failure with preserved EF." 61st Congress of European-Renal-Association (ERA) , Stockholm, Sweden.

@conferencepaper{conferencepaper, author={ÖZANT HELVACI Et Al. }, title={Evaluation of the effect of IV iron therapy on eGFR and Pro-BNP in patients with chronic kidney disease and heart failure with preserved EF}, congress name={61st Congress of European-Renal-Association (ERA)}, city={Stockholm}, country={Sweden}, year={2024}}